In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 60 for your search:
Treatment/Intervention:  complementary or alternative medicine procedure
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: CA151445, R01CA151445, NCT01281904

2.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689

3.

Phase: Phase III
Type: Natural history/Epidemiology
Status: Active
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000617778, S0000B, U10CA037429, R01EY014418, SWOG-S0000B, NCT00784225

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 128308, NCI-2009-01530, P30CA016056, RPCI-I-128308, NCT00887432

5.

Phase: Phase III
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2010-0547 MDA, MDA-04-01, CDR0000674208, 2010-0547, NCI-2011-02073, NCT01141231

6.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2010-0584, NCI-2011-00306, R01CA148707-01A1, NCT01266044

7.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 4 to 18
Sponsor: NCI, Other
Protocol IDs: SCUSF 1202, Previously COG-ACCL1032, 5U10CA081920, COG-ACCL1032, ACCL1032, NCT01346267

8.

Phase: Phase III
Type: Health services research, Supportive care
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: 1R01CA127493-01A2, NCT01365182

9.

Phase: Phase III
Type: Supportive care, Tissue collection/Repository, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000716291, NCCTG-N10CB, N10CB, NCT01473290

10.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: S1200, R01AT000636-01, U10CA037429, NCI-2012-00251, SWOG-S1200, NCT01535066

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000727295, NCCTG-N11C5, N11C5, NCT01545687

12.

Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 30 to 70
Sponsor: NCI, Other
Protocol IDs: 1R21CA106336-01A1, NCT00156416

13.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01434, CDR0000671302, NCI09-13-02, NWU09-13-02, N01CN35157, P30CA060553, NU-NWU09-13-02, NCT01111292

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000579360, UAB-F060511015, UAB-IRB0000196, F060511015, NCT00703196

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 50
Sponsor: NCI, Other
Protocol IDs: S0812, U10CA037429, NCI-2011-02032, SWOG-S0812, NCT01097278

16.

Phase: Phase II
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 11 to 24
Sponsor: NCI, Other
Protocol IDs: ANUR1131, NCI-2012-00682, COG-ANUR1131, CDR0000726664, U10CA095861, R01CA162181, NCT01556256

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: MC084C, NCI-2012-00058, NCT01606124

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: 11165, R01CA160938, NCT01661764

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 98113, NCI-2013-00963, P30CA012197, NCT01869764

20.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: IRB00062853, R21AT007090, NCT01926678

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 45 to 85
Sponsor: NCI, Other
Protocol IDs: CASE6812, NCI-2013-01372, P30CA043703, NCT01928485

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00695, CO11378, UWI2013-00-01, P30CA014520, N01CN00033, N01CN35153, NCT02095145

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE5913, NCI-2014-00266, P30CA043703, NCT02100423

24.

Phase: Phase I
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: Pro00000581, P50CA108786, P30CA014236, SPORE Project 3, CDR0000579683, DUMC-PRO00000581, NCT00626483

25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: CDR0000596506, P30CA016056, RPCI-I-90206, I 90205, NCT00690924
1    
New Search